Bernard W. Futscher, PhD

Professor, Pharmacology and Toxicology

Associate Professor, BIO5, Institute for Collaborative Research 
Assistant Research Scientist, Cancer Center Division
Investigator, Center for Toxicology

Arizona Cancer Center, Room 3925

P.O. Box 245024
Tucson, Arizona 85724-5024

(520) 626-4646
Email Address:

Fax: (520) 626-2416

  • Loyola University, Chicago, 1990 (Ph.D.)
Honors & Awards: 

NIH R29 First Award

Major Areas of Research Interest: 
  • Molecular mechanisms by which 5-methylcytosine influences structure and function during human carinogenesis.
  • Functional genomics and epigenomics
  • Molecular biology of cancer
  • Cancer pharmacology
Selected Publications: 

Crowley-Weber CL. Payne CM. Gleason-Guzman M. Watts GS. Futscher B. Waltmire CN. Crowley C. Dvorakova K. Bernstein C. Craven M. Garewal H. Bernstein H. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis. 23(12):2063-80, 2002.

List AF. Spier C. Greer J. Wolff S. Hutter J. Dorr R. Salmon S. Futscher B. Baier M. Dalton W. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. Journal of Clinical Oncology. 11(9):1652-60, 1993.

Micetich KC. Futscher B. Koch D. Fisher RI. Erickson LC. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer. Journal of the National Cancer Institute. 84(4):256-60, 1992.

Sponsored Research Through MSRP: 

Megan O'Meara (MSRP 2001, 2002): "Loss of Maspin Expression in Ductal Carcinoma of the Breast."

Advanced Research - Research Distinction Track (RDT): 

Megan O'Meara (Class of 2005): "Loss of Maspin Expression in Ductal Carcinoma in situ of the Breast."

Last Updated: 
November 18, 2015